Operating

Change in Inventories

West Pharmaceutical Services Change in Inventories remained flat by 0.0% to $15.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 249.5%, from -$10.50M to $15.70M. Over 4 years (FY 2021 to FY 2025), Change in Inventories shows a downward trend with a -7.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026

How to read this metric

A decrease is often positive as it signals efficient inventory turnover and cash release, provided it does not lead to stockouts.

Detailed definition

This metric tracks the change in the value of raw materials, work-in-progress, and finished goods held by the company. A...

Peer comparison

Highly dependent on industry; manufacturing and device companies typically maintain higher inventory levels than software firms.

Metric ID: change_in_inventories

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$86.50M$49.80M$13.50M-$42.00M$62.80M
YoY Change-42.4%-72.9%-411.1%+249.5%
Range-$42.00M$86.50M
CAGR-7.7%
Avg YoY Growth-69.2%
Median YoY Growth-57.7%

Frequently Asked Questions

What is West Pharmaceutical Services's change in inventories?
West Pharmaceutical Services (WST) reported change in inventories of $15.70M in Q4 2025.
How has West Pharmaceutical Services's change in inventories changed year-over-year?
West Pharmaceutical Services's change in inventories increased by 249.5% year-over-year, from -$10.50M to $15.70M.
What is the long-term trend for West Pharmaceutical Services's change in inventories?
Over 4 years (2021 to 2025), West Pharmaceutical Services's change in inventories has grown at a -7.7% compound annual growth rate (CAGR), from $86.50M to $62.80M.
What does change in inventories mean?
The change in the value of products and materials held in stock.